Submission

ABSTRACT TOPICS

Artificial Intelligence, Machine Learning, Big Data, Deep Learning, Artificial Neural Networks, Robotics, Biostatistics, Epidemiology, Biometrics, Computational Biology, Artificial Intelligence, Big Data, Bioethics, Bioinformatics, Biomedical Engineering, Medical Education, Medical Publishing, Medical Robotics, Medical Universities, Teaching Biostatistics, Teaching Medicine, Teaching Research Methods,  and more.

SUBMISSION STEPS

1) Please upload your abstract via the form below. Following our confirmation, complete your payment at the registration page. Your abstract will be published in the congress abstract book. 

2) If you would like to have an oral presentation, please inform us so our technical department will contact you accordingly for the recording date and time. There is no extra charge for oral presentations. You can make your presentation in any language you like, but please do not forget to send us the English text of your oral presentation to add it as the subtitle. 

3) Oral presentation can be a minimum of 15 and a maximum of 20 minutes.

For more information: ai@medicres.org

* Poster / Oral Presentation Submission

Abstract Submission
arrow&v
arrow&v
arrow&v
Add a Document
Add a Video
Add an Image

Thanks for submitting!

Abstract Submission Rules

Abstracts can only be submitted via the online registration form and the abstract submission system of MedicReS. 

The submission deadline is 12:00 Vienna Local Time / December 31st, 2022.

No further extension will be possible.

 

General Information

One author can submit a maximum of 5 abstracts for poster or oral presentations, full texts of correspondence letters, or research proposals for oral presentations.

 

Step 1: Abstract Information

Title

A maximum of 200 characters typed in lower-case letters, except for abbreviations and study names. Please be careful that your title is not truncated if you copy and paste it into the field.  Please include authors, institutions, city names, trademarks, and abbreviations in the title.

 

Topic

At the time of abstract submission, the submitter must select at least one maximum of 5 topics to index the abstract.

It is important to select the best matching topic as this choice will carefully determine under which area the abstract will be reviewed and graded.

 

Category

You must select one of the following categories ( study design ) under which your abstract can be best classified :

 

Case report / Case Series

Comparative Case series

Case-Control / Nested Case-Control

Cohorts / Retrospective Cohorts

 

Correspondence Letter

Clinical Trials / Randomized Clinical Trials

 

Survey with High Response Rate / Cross-Sectional

Cost-Effectiveness Analysis

Decision Analysis

Study of Screening and Diagnostic Tests

​Translational Research,

Animal experiments

Registries

Systematic Reviews and Meta-Analysis

Others

 

Guideline for Correspondence Letters

 

Letters discussing a recent article in this journal should be submitted within a maximum of 1 year of the article's publication in print.

400 words, ≤5 references (1 of which should be to the recent article),  ≤3 authors

For further info pls, click https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548563/pdf/tju-39-supp-41.pdf

 

Options

You may choose to submit your abstract under one of the following options:

Funding acknowledgments

All sources of financial support (including government grants) for this research must be filed under this heading and not in the abstract text. All grant funding agency abbreviations should be spelled out. This information will be published in the abstract itself.

The submitter is asked to indicate the type of funding source(s) and name it/them, if any.

Step 2: Abstract Authors and Institutions

Your abstract must list at least one author to be submitted.

 

Authors' list

Please note that the first author should be the abstract presenter by default. Nevertheless, it can be modified through the online agreement form as of May 2021. In all cases, the presenter must be part of the authors' list included in the submitted abstract and be able to explain his/her role in the research during the presentation. You may enter up to 15 authors in the authors' list, including the presenter. If you have more than 15 authors, you can use the 'On behalf of field (see above) to enter the name of an investigating team/study group.

The authors' names will be published as listed on the submission form. Please ensure you have entered the full list of authors - official contributors in the research submitted - and that the information given for each author is correct. No changes will be possible after the abstract is submitted (see paragraph on changes and corrections above).

The authors’ order and details (names, cities, country codes) will be published, as entered by the submitter.

The submitter certifies and warrants to the MedicReS that the list of authors is complete, that he/she has permission from all persons he/she enters as co-authors to be listed in this abstract, and that they are aware that their names will appear in all publications.

If none of the authors can present the abstract during the congress, the abstract should be withdrawn. If not, it will be considered a 'no-show,' and the MedicReS Congress Programme Committee can decide not to consider an abstract submitted by the same author the following year.

 

Institutions

This is a mandatory step.

 

You will be requested to select your institution when you create the presenter and the authors.

Once you have entered your city, a list will automatically appear from which you can select your institution.

If your institution is not on the list, you have the possibility of creating it.

If your city is not on the list, please enter it, press 'enter, and add your institution.

 

Step 3: Abstract Content

All abstracts must be submitted (and will be presented) in English.

Abstracts must contain original material neither published nor presented elsewhere (in print or electronically) before MedicReS World Congress 2021.

According to the national law, if applicable, abstracts submitted on animal studies must follow the 'principles of laboratory animal care (NIH Publication No. 85-23, revised 1985).

Do not cut and paste symbols into your text. Use the symbols when you click the omega button (Ω).

We recommend you structure your abstract using the following headings:

 

Background / Introduction

Purpose ,Methods, Results ,Conclusion(s)

 

There is not a specific maximum of words, but rather a maximum total size for the abstracts (shown as 100%), including the text with spaces and tables (if any). The maximum abstract size is 35 lines (3,000 characters).

Use the 'save' and 'refresh' buttons at the bottom to display the abstract's size in percentage terms (shown on the left of the screen). The program converts the size into a percentage when you save it as a draft.

The character limit does not include the title and authors. Only the abstract text, tables, and spaces are considered.

 

Abstract table for only poster presentations

The table field holds a table without surrounding text. Do not copy your table into the field. You must recreate your table using the tools provided.

The maximum size of the table is 12 columns and 20 rows, and you can only enter one table. The title field is optional.

In addition to your text, you can add a picture.

 

Abstract picture for only poster presentations

Your picture file must meet the following criteria:

Format: Jpeg or.GIF

Size: less than 1 MB

Measures no larger than 800 pixels(x) x 600 pixels(y)

Please ensure that your picture is readable on the abstract preview (this represents how it will look in all publications). You can only enter one picture, and the title field is optional.

Important: As the grading and selection process is blind, the title and body text must not contain identifying features, i.e., information such as:

Names (authors or others)

Names of the institutes (hospitals, medical schools, clinics…)

Cities

Also not authorized

Trademarks. The use of commercial drug names, brands, and registered trademarks is strictly prohibited. Instead, use generic drug names. Drugs should be referred to by their active substances or pharmacological designations.

Company names and locations.

Websites and email addresses.

Failure to comply with the above requirements will/may lead to automatic rejection of the submission, or this information may be deleted by the abstract services, and some rephrasing may occur.

Furthermore, the Abstract Reviewing Committee (graders) is required to identify abstracts that pertain to the commercial promotion of a proprietary product and to notify the selection committee.

Do not include grant acknowledgments in the abstract content. Use the appropriate field.

Do not cite keywords or references in the abstract; they are not allowed and will be deleted.

Do not include copyright or trademark symbols.

Limit the use of acronyms and abbreviations. Define at first use with an acronym or abbreviation in parentheses.

Please note that any medical research involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association. Remember that the patient’s photo should not be used, and the patient must never be identifiable in your presentation.

 

Step 4: Abstract Preview and Submission

Proofread abstracts carefully to avoid errors before submission, and check spelling and grammar. The abstract will be reviewed and published (if accepted) as it has been submitted – No Exceptions!

Do not forget to click on the 'submit' button to validate your abstract submission. After submitting your abstract, you will receive an immediate automatic confirmation by email (please make sure to state your correct email address!) notifying you of the abstract number. Please use this reference in all correspondence. If you do not receive this confirmation, please contact the Abstract Team.

There is a limit to the number of abstracts ( 5 )  an author/individual may submit, but the same research cannot be submitted twice, even under a different topic/category or with a different title. If you submit two abstracts with the same content, the Abstract Submission Service will automatically keep the most recent abstract submitted and withdraw the other. Note that duplicate draft abstracts will not be deleted.

 

If you have difficulties submitting your abstracts or need any further information, please contact the Abstract Team via info@e-picos.com.

Abstract grading/results

All abstracts are blind and will be reviewed by seven to 10 members of the Abstract Reviewing Committee (graders). The MedicReS Congress Program Committee selects each grader to review abstracts in the category that best fits their expertise.

Our intent is to be most inclusive of the quality science received without compromising scientific integrity.

The Abstract Reviewing Committee (graders) must identify abstracts about the commercial promotion of a proprietary product and notify the selection committee.

Abstracts submitted for consideration must be an original idea, concept, or an improvement or revision of a previous idea. Submissions are peer-reviewed for scientific content, logical presentation, and current interest in the topic to the scientific community.

 MedicReS Congress Program Committee will make the final selection, determining each abstract's format, day, and presentation time. No scheduling or changes will be possible.

Accepted abstracts will be scheduled either as oral presentations, Moderated posters, or half-day Poster Presentations.

All presentations will include questions and answers conducted in English. Presenters are expected to speak good English.

All abstract submitters will be notified by email in early April 2021 about the review-and-selection process's outcome (accepted or not accepted).  Please ensure that the email provided is accurate because all correspondence will be sent via email.

If the abstract is accepted, instructions and guidelines concerning the abstract presentation will be provided online.

The same presenter cannot be assigned to more than five abstracts - co-authors should then be assigned as presenters.

 

No-show policy

Submission of an abstract constitutes a formal commitment by the author(s) to present the work if accepted. Failure to present and register for the congress, if not justified (withdrawn), will be identified as a 'no-show' and jeopardize future acceptance of abstracts. In addition, abstracts identified as 'no-shows' will be removed from all congress publications (including MedicReS 365).

 

Publication of abstracts

All presented abstracts will be published in the Abstracts and Conference Proceedings Books of MedicReS.

You consent to have authors’ names, affiliations, and biographical material used in connection with the publication of your work.

Author(s) represents and warrants to the MedicReS that he/she/they is/are the sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, and that the work is original and does not infringe upon any copyright, proprietary, or personal right of any third party.

The submitter hereby affirms that the work submitted is original, except for extracts from copyrighted works fully authorized by the copyright holders and that all statements declared as facts are based on thorough examination and investigation for accuracy.

Submitted abstracts should not have been published in any other journals and/or online publications nor presented at any previous international congress. However, previous presentations at national and/or non-cardiovascular specialist meetings do not qualify.

A submitter, presenter, or co-author submitting or presenting previously published work will lead to:

Withdrawal of their presentation from the press conference and/or scientific session.

Prohibition against submitting abstracts to any MedicReS congresses for one year.

They submit abstracts that must report new information not previously published or presented at a national or international scientific meeting before the congress. Note that abstracts previously presented at meetings will not be accepted unless there is a substantial data update.

Identified duplicates will be retracted from all related MedicReS publications.

The content belongs to the author(s). However, if the abstract is accepted, the submitter agrees, on behalf of all co-authors, to transfer and assign to the MedicReS free of charge on a non-exclusive basis – for 15 years from the present submission – the rights to edit, publish, reproduce, reformat, distribute in whole or in part the abstract and to prepare all types of derivative works, such as press releases and/or educational products, using all communication tools and means, now known or hereinafter developed, including any and all digital means and any and all supports or forms of media now known or hereinafter developed, in particular all paper, analog, digital, numerical and electronic media, including Internet, Intranet and Extranet sites and social media. This includes use in indexes or search databases in print, electronic, or other media.

Author(s) retain the right, after presentation at the congress, to subsequently include the work in articles, books, or derivative works that he/she authors or edits, provided said use does not imply the endorsement of the MedicReS.

The submitter signs for all co-authors. He/she accepts responsibility for the present rules for submission and presentation on behalf of all co-authors.

 

Conflict of interest

The E-PICOS Conference Program Committee requests that all presenters display a slide at the beginning of their presentations (at the bottom of the poster for Poster Presentations) indicating disclosure information for themselves and all co-authors, as applicable, or to indicate that they have nothing to disclose. Please state 'none' if no conflicts exist.

This will allow the audience to consider potential conflicts of interest when assessing the presentation's objectivity.

A potential conflict of interest may arise from various relationships, past or present, such as employment, consultancy, investments and stock ownership, funding for research, family relationships, etc.

All potential conflicts of interest must be stated.

This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the article's subject matter. Such relationships include, but are not limited to, employment by an industrial concern, ownership of stock, membership on a standing advisory council or committee, being on the board of directors, or being publicly associated with a company or its products. Other areas of a real or perceived conflict of interest could include receiving honoraria or consulting fees, grants, or funds from corporations or individuals representing such corporations.

 

Data privacy

By certifying that you have read these submission rules, you also confirm having received prior approval from your co-authors to provide their data to the MedicReS.

The information collected in this Call for Abstracts is subject to data processing for elaborating the E-PICOS World Conference 2022 Abstract-Based Program.

Provision of personal data is required to list authors who have contributed to the research submitted. Authors not listed in the submission will not be acknowledged in the abstract, and promotion of the abstract – is accepted for publication and presentation at the congress.

Recipients of the data are MedicReS staff who process the submissions and the MedicReS committees and volunteers involved in the Abstract–Based Program.​​​​​